ArticleAlzheimer's & dementia (New York, N. Y.)

Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease.

Ivelina Gueorguieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.